Trimethoprim resistance was investigated in cystic fibrosis isolates of Pseudomonas cepacia. Determination of the MIC of trimethoprim for 111 strains revealed at least two populations of resistant organisms, suggesting the presence of more than one mechanism of resistance. Investigation of the antibiotic target, dihydrofolate reductase, was undertaken in both a susceptible strain and a strain with high-level resistance (MIC, >1,000 ,ug/ml). The enzyme was purified by using ammonium sulfate precipitation, gel filtration, and ion-exchange chromatography. Specific activities, molecular we;ghts, isoelectric points, and substrate kinetics were similar for both enzymes. However, the dihydrofolate reductase from the trimethoprim-resistant strain demonstrated decreased susceptibility to inhibition by trimethoprim and increased susceptibility to inhibition by methotrexate, suggesting that these two enzymes are not identical. We conclude that the mechanism of trimethoprim resistance in this strain with high-level resistance is production of a trimethoprim-resistant dihydrofolate reductase.
may be associated with a rapid deterioration of clinical status (24) . In a subpopulation of female adolescents with advanced pulmonary disease, severe necrotizing pneumonia and death have occurred (21) .
An important problem in the treatment of infections caused by P. cepacia is the high incidence of antibiotic resistance. CF isolates, in particular, are often resistant to the P-lactam agents and aminoglycosides used to treat infections caused by Pseudomonas aeruginosa (4, 7, 11) . Trimethoprim is an agent which has demonstrated both in vitro and in vivo efficacy against P. cepacia, but up to 60% of isolates from CF patients are resistant to trimethoprim (14) . Resistance mechanisms which have been described for trimethoprim include decreased permeability, synthesis of a trimethoprim-resistant dihydrofolate reductase (DHFR), or overproduction of the constitutive, trimethoprim-susceptible enzyme (13) . This study describes the isolation and characterization of DHFR from trimethoprim-susceptible and trimethoprim-resistant strains of P. cepacia.
MATERIALS AND METHODS
Materials. Trimethoprim, dihydrofolic acid, 1-NADPH, and purified bovine liver DHFR were purchased from the Sigma Chemical Co., St. Louis, Mo Isoelectric focusing. Isoelectric focusing of DHFR was performed using the technique of Eder (9) . Polyacrylamide tube gels containing ampholytes in the pH range of 5 to 8 were used for electrophoresis, and the DHFR band was identified by using the method of Hiebert et al. (12) to stain for enzyme specific activity.
Peptide mapping. Peptide mapping in SDS-polyacrylamide gels was performed by the method of Cleveland et al. (8) by using trypsin and V8 protease to partially digest each protein. The enzymes were electroeluted for 6 h at 20 mA from nondenaturing 10% polyacrylamide gels into Tris-glycine buffer (pH 8.3). Protein samples (15 ,ug) were boiled for 2 min at 100°C, and then proteolytic digestions were performed overnight with trypsin (37°C) and V8 protease (25°C) at a concentration of 25 ,ug/ml. SDS and ,3-mercaptoethanol were added, and the samples were run on a 15% SDSpolyacrylamide gel and visualized by silver staining (26) .
Determination of kinetic parameters. The K,,, and V1max of dihydrofolic acid were determined by using the spectrophotometric assay described above. The experiments were performed to determine the effect of known inhibitors of DHFR upon the activities of enzymes isolated from trimethoprim-susceptible and -resistant strains of P. cepacia. These experiments also used the spectrophotometric assay; however, the inhibitor, either trimethoprim or methotrexate, was incubated with purified enzyme, buffer, and NADPH for 1 min prior to the addition of dihydrofolic acid to initiate the reaction. Trimethoprim concentrations ranged from 10-12 to 10-3 M; methotrexate concentrations ranged from 10-12 to 10-7 M. RESULTS MIC determinations. A total of 111 P. cepacia CF isolates were tested for trimethoprim susceptibility; 68 (61%) were resistant (MIC, .10 ,ug/ml). A histogram of the distribution of MICs is shown in Fig. 1 . There appeared to be at least three distinct populations of bacteria: one which was susceptible, a second which had relatively low-level resistance, and a small number of strains which exhibited high-level resistance. This suggested that two different resistance mechanisms were operating in P. cepacia. A susceptible isolate, PC174 (MIC, 1 pg/ml), and a highly resistant isolate, PC178 (MIC, >1,000 ,ug/ml), were selected in which to characterize DHFR. "Percent DHFR activity remaining after heating to 45'C for 10 min.
Enzyme purification. A comparison of the purification of DHFR from strains PC174, the susceptible isolate, and PC178, the resistant strain, is shown in Table 1 . For strain PC174, the ammonium sulfate fraction containing the maximum activity was 50 to 70%; for PC178, it was the 40 to 60% fraction. No peak of DHFR activity was identified in other fractions. A single band was identified in the active fraction from each strain using enzyme-specific staining. The specific activities of both enzymes were similar in crude extracts (0.02 U/mg of protein), and the overall recovery was approximately 25% in both strains. The PC174 enzyme was purified 287-fold; PC178 was purified 512-fold.
Characterization of the enzymes. A comparison of the physical and kinetic properties of DHFR isolated from the trimethoprim-susceptible strain PC174 and the trimethoprim-resistant strain PC178 is shown in Table 2 . The molecular weights of the two enzymes were similar, 24 ,000 and 23,000, respectively, and the isoelectric points (pl) were identical. The K,,, and Vmax for dihydrofolate were also similar in the enzymes from the two strains. Both enzymes were heat stable. The protein fingerprints of the enzymes as determined by peptide mapping with V8 protease showed a change in electrophoretic mobility of a single band (Fig. 2) ; with trypsin there were no detectable differences (data not shown).
Inhibition studies. Because the physical and chemical properties of the two enzymes were quite similar, the effects of potential inhibitors of DHFR activity were investigated to determine if trimethoprim resistance is due to the production of a resistant DHFR. The susceptibilities of the two enzymes to trimethoprim differed markedly (Fig. 3A) . The concentrations of trimethoprim at which 50% of the DHFR activity was inhibited (150) were 0.0012 ± 0.0003 FM for PC174 and 0.0750 ± 0.0160 F.M for PC178, nearly a 2-log difference. The I15S for methotrexate also differed between the two enzymes, 0.0011 ± 0.0003 F.M for PC174 and 0.0003 ± 0.0002 F.M for PC178 (Fig. 3B) . Thus, the DHFR isolated from the trimethoprim-susceptible strain PC174 was more sensitive to trimethoprim but less sensitive to methotrexate than that from the trimethoprim-resistant strain. DISCUSSION Antibiotic resistance is a frequently encountered problem in the therapy of P. cepacia pulmonary infections in children and young adults with CF. Because this ubiquitous gramnegative organism has a high level of resistance to many hydrophilic and hydrophobic antimicrobial agents, it is presumed that resistance is due to a generalized decreased outer membrane permeability. Parr et al. (20) have described intrinsic resistance to 3-lactam antibiotics due to the low outer membrane permeability coefficient associated with a small porin channel size. Aronoff (1) laboratory (6) has reported decreased cellular uptake of chloramphenicol unassociated with structural changes in the outer membrane proteins or lipopolysaccharide. In addition, Moore and Hancock (18) have described decreased susceptibility of P. cepacia to the outer-membrane-permeabilizing action of polymyxin and the aminoglycosides.
Trimethoprim resistance may also be due to decreased outer membrane permeability; however, overproduction of chromosomal DHFR and the plasmid-mediated synthesis of a trimethoprim-resistant DHFR are more common mechanisms of resistance (13) . Overproduction of a susceptible enzyme has been reported in both gram-positive and gramnegative organisms, and promoter mutations have been described which result in a 10-to 200-fold increase in DHFR activity (10, 22) . Baccanari et al. (3) have isolated and characterized D1-FR from an Escherichia coli strain with a trimethoprim MIC of >500 ,ug/ml, which demonstrates a 300-fold overproduction of constitutive enzyme.
Nine plasmid-encoded trimethoprim-resistant DHFR enzymes have been characterized, all of which appear to have an alteration in the active site of the enzyme (for a review, see reference 13). Although they are called plasmid-mediated enzymes, the genes that code for resistant DHFR may also be carried on transposable elements or may be chromosomally located because of integration into the bacterial chromosome. These enzymes range in molecular mass from 16.9 findings of similar specific activity, molecular weight, pl, and Km and Vmax for dihydrofolic acid suggest that the susceptible and resistant enzymes are similar in primary structure. This is confirmed by the peptide patterns resulting from protease digestion. However, DHFR from the resistant strain demonstrated a decrease in sensitivity to trimethoprim inhibition compared with that of the susceptible isolate. These findings suggest that the difference between the DHFR isolated from the susceptible and resistant strains results from a modification of the active site of the enzyme. Because a 2-log decrease in trimethoprim sensitivity does not fully explain a greater than 1,000-fold increase in MIC, it is possible that strain PC178, the resistant isolate, also has a decrease in permeability to the trimethoprim. Further characterization of DHFR from P. cepacia will include genetic analysis using previously identified resistance genes to probe strain PC178 to determine whether this is a novel DHFR or one of the already described trimethoprinm-resistant enzymes.
